* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 1. Type I allergy
Complement system wikipedia , lookup
DNA vaccination wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Immune system wikipedia , lookup
Food allergy wikipedia , lookup
Autoimmunity wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Adaptive immune system wikipedia , lookup
Molecular mimicry wikipedia , lookup
Innate immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Go Back to the Top To Order, Visit the Purchasing Page for Details Table 3.3 Main cytokines secreted by keratinocytes. Classification, cytokines Main functions Multifunctional cytokines IL-1a IL-6 IL-7 IL-12 IL-15 IL-18 TNF-a MIF Induction of secondary cytokines 6444447444448 Interleukin (IL) Modulation of adhesion molecules Modulation of activation and migration of T cells, B cells and macrophages Activation of endothelial cells and fibroblasts Modulation of activation and migration of Langerhans cells (IL-1a, TNF-a) Induction of fever and acute inflammatory proteins Chemotactic factor: associated with leukocyte migration IL-8 Activation and migration of T cells and neutrophils Colony stimulating factor: associated with leukocyte proliferation GM-CSF Activation of granulocytes, macrophages, T cells and Langerhans cells G-CSF Proliferation of granulocytes M-CSF Proliferation of macrophages Growth factor: associated with local cutaneous reactions TGF-a Proliferation of keratinocytes b-FGF, PDGF Proliferation of fibroblasts and endothelial cells Suppression factor: modulates immunity TGF-b Suppression of keratinocytes and endothelial cells IL-10 Suppression of immunity through Th1 cells IL: interleukin, TNF: tumor necrosis factor, MIF: macrophage migration inhibitory factor, GM-CSF: granulocyte macrophage colony-stimulating factor, G-CSF: granulocyte colony-stimulating factor, M-CSF: macrophage colony-stimulating factor, TGF: tumor growth factor, b-FGF: basic fibroblast growth factor, PDGF: platelet derived growth factor C. Immunity, Allergic reactions Skin is a major organ where immune/allergic reactions occur. Various skin diseases have been increasingly understood by the concept of immunity and allergic reactions, which are generally classified into the four categories established by Coombs & Gell (Table 3.4). 1. Type I allergy Type I allergy is caused mainly by mast cells. Since a reaction occurs 5 to 15 minutes after an antigen (allergen) is administered, it is also called an immediate hypersensitivity. Mast cells with IgE on the surface react to antigens, and chemical mediators such as histamines and leukotrienes are then secreted by the mast cells (Chapter 8). These chemical mediators enhance vascular permeability, to produce edema; in addition, they induce migration of 3 46 3 Immunology of the Skin eosinophils, to evoke inflammation. Therefore, nasal discharge, pruritus, and bronchial asthma are induced, and blood pressure is decreased, by vascular dilatation. A patient with these symptoms may undergo anaphylactic shock in serious cases. The symptoms are transient and usually subside within several hours. Typical skin diseases caused by type I allergy are urticaria and certain types of drug eruptions (urticarial reaction). Other factors are involved in atopic dermatitis; however, IgE plays a pivotal or even solo role in the pathogenetic process. Additionally, allergic rhinitis (hay fever) and allergic bronchial asthma are common diseases caused by type I allergy. 3 2. Type II allergy In type II allergy, antibodies are produced against the antigen on the cell surface to which complements and cytotoxic T cells have been activated, thereby injuring the cells. Type II allergy induces cutaneous diseases such as autoimmune blistering diseases. In bullous pemphigoid, autoantibodies bind to BP180 (BPAG2) in the basal cell hemidesmosomes, and the basal cells are injured by Type II allergy, resulting in blisters (Chapter 14). A drug may function as a hapten to bind with epidermal cells or blood cells to cause Type II allergy. Drug-induced hemolytic anemia, thrombocytopenic purpura, and toxic epidermal necrolysis (TEN) occur by this mechanism. Table 3.4 Classification of allergy. Coombs classification Type III Type IV Immune complex reaction Cellular immunity (delayed hypersensitivity) Type II Type I Type of reaction Anaphylaxis (immediate Cytolytic reaction hypersensitivity) Associated antibodies IgE IgG, IgM IgG, IgM - Associated immune cells Histiocytes, basophils, mast cells Cytotoxic T cells, macrophages Multinuclear leukocytes, macrophages Sensitized T cells, macrophages Complement Unneeded Needed Needed Unneeded Target tissues/cells Skin, lung, intestines Skin, erythrocytes, leukocytes, platelets Skin, vessel, joint, kidney, lung Skin, lung, thyroid gland, central nervous system, etc. Disorders Urticaria, drug eruption, Bullous pemphigoid, hemolytic anemia, idiopathic asthma, pollinosis, thrombocytopenic purpura, TEN, anaphylaxis transfusion incompatibility Illustration of reaction IgE FC receptor antigen cytotoxic T cell IgG or IgM IgE cytolysis Allergic contact dermatitis, Cutaneous small-vessel vasculitis, serum sickness, erythema induratum, GVHD glomerulonephritis immune complex complements IgG complements secretion of chemical mediators such as histamine surface antigen phagocytes tissue antigen effector T cells APCs secretion of cytokines such as IFN-g activated macrophage C. Immunity, Allergic reactions Blood group incompatibility from transfusion, autoimmune hemolytic anemia, and Goodpasture syndrome are also Type II allergies. 3. Type III allergy Type III allergy occurs when antigen-antibody complexes (immune complexes) deposit in the blood vessels and specific sites of tissue. An infection or a drug induces immune complex deposition, where an allergic reaction causes fibrinoid degeneration and neutrophilic infiltration; this is called cutaneous smallvessel vasculitis (Chapter 11). Serum sickness disease, glomerular nephritis and lupus nephritis are also type III allergies. MEMO Phagocytic cells engulf antigens that contain proteins of 10,000 molecular weight or greater (complete antigen) and carry the information of the antigens to lymphocytes. That is, non-protein substances of small molecular weight (e.g., carbohydrates, fats, organic compounds, metallic molecules) cannot be antigens themselves; they are called haptens, or incomplete antigens. Although antibodies react to haptens individually, lymphocytes produce such antibodies only in combination with other proteins. Hapten 4. Type IV allergy Type IV allergy is inflammation caused by a reaction between an antigen and the corresponding T cells (Th1 in particular). There are two stages in type IV allergy: sensitization, and an effector phase. After an initial invasion, the antigen is engulfed by antigen-presenting cells to activate T cells in the regional lymph nodes. At this time, memory T cells along with effector T cells are produced in order to enable them to respond promptly to the secondary invasion of the antigen (sensitization). In the secondary and later invasions, memory T cells are activated by the antigen-presenting cells, and inflammation is evoked that peaks 48 hours after antigenic challenge (effector phase). Since it takes a long time for the reaction to occur, Type IV allergy is also ② contact with the same antigen (challenge phase: 24-48 hrs) ① first contact with antigen (sensitization: about 1 week) allergen (antigen) papules, vesicles spongiosis cytokines Langerhans cell migration to lymph node T cell antigen presenting by Langerhans cell memorization presents antigen information lymph node Fig. 3.9 Mechanism of allergic contact dermatitis. effector T cell (Th 1) 47 edema inflammatory-cell infiltration telangiectasia 3 48 3 Immunology of the Skin called delayed hypersensitivity (Fig. 3.9). Typical lesions caused by type IV allergy are allergic contact dermatitis and graft-versus-host disease (GVHD). 3 D. Immune abnormality 1. Autoimmune diseases Immunity is a mechanism whereby self is distinguished from non-self to exclude non-self. Therefore, autologous proteins do not usually induce immune reactions. If there is a disturbance in the body, antibodies (autoantibodies) are produced against autologous proteins and the immune mechanism tries to exclude self; this phenomenon is called autoimmunity, and the diseases caused by it are called autoimmune diseases. Autoantibodies are thought to appear by the following mechanisms. ●Organs that have been isolated from the immune system since the embryonic phase are exposed to the immune system for an unknown reason and are recognized as non-self (e.g., sympathetic opthalmia, azoospermia). ●Normal tissues are degenerated by viruses or bacteria, and antibodies are produced against the degenerated proteins (e.g., mycoplasma pneumonia). ●Antibodies that have been produced against specific bacteria react with similar self antigens (cross-reaction) (e.g., rheumatic fever). ●Immunologic homeostasis becomes dysfunctional somehow, and lymphocytes that react against autoantigens (forbidden clones), which are excluded in a normal state, are not excluded (some autoimmune diseases, including systemic lupus erythematosus (SLE)). ●Regulatory T cells suffer reduced function for some reason, and immune reactions to self become uncontrolled (some autoimmune diseases, including SLE). The major autoimmune diseases that are treated in dermatological practice include SLE, systemic sclerosis (SSc) and autoimmune blistering diseases such as pemphigus and pemphigoides. 2. Immunodeficiency Immunodeficiency is subclassified into congenital and acquired. In congenital immunodeficiency, the immune factors are congenitally lacking. In acquired immunodeficiency the cause is secondary – the result of a disease or treatment. Different factors are dysfunctional in each disease, resulting in immunodeficiencies such as hypogammaglobulinemia, lymphocytopenia and the decrease of compliment titer. In congenital immunodeficiency diseases, the infection is often Go Back to the Top To Order, Visit the Purchasing Page for Details